Fluvoxamine

• Common antidepressant may help adults with long COVID: study

  The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'

  Health

  Apr 2
  
• Cheap antidepressant could help treat COVID-19, study finds

  A new clinical trial has found that fluvoxamine — commonly used to treat depression — seems to reduce the risk of hospitalization with COVID-19.

  Health

  Oct 27, 2021
  
• Advertisement
• McMaster study points to effective treatment for COVID-19 using common antidepressant

  A recent observational study is showing promise for an oral treatment for COVID-related symptoms.

  Health

  Aug 19, 2021